Literature DB >> 9843739

Stimulatory effect of insulin on creatine accumulation in human skeletal muscle.

G R Steenge1, J Lambourne, A Casey, I A Macdonald, P L Greenhaff.   

Abstract

This study investigated the effect of insulin on plasma and muscle creatine accumulation and limb blood flow in humans after creatine administration. Seven men underwent a 300-min euglycemic insulin clamp combined with creatine administration on four separate occasions. Insulin was infused at rates of 5, 30, 55, or 105 mU. m-2. min-1, and on each occasion 12.4 g creatine was administered. During infusion of insulin at rates of 55 and 105 mU. m-2. min-1, muscle total creatine concentration increased by 4.5 +/- 1.4 (P < 0. 05) and 8.3 +/- 1.0 mmol/kg dry mass (P < 0.05), and plasma creatine concentrations were lower at specific time points compared with the 5 mU. m-2. min-1 infusion rate. The magnitude of increase in calf blood flow (plethysmography) was the same irrespective of the rate of insulin infusion, and forearm blood flow increased to the same extent as the three highest infusion rates. These findings demonstrate that insulin can enhance muscle creatine accumulation in humans but only when present at physiologically high or supraphysiological concentrations. This response is likely to be the result of an insulin-mediated increase in muscle creatine transport rather than creatine delivery.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9843739     DOI: 10.1152/ajpendo.1998.275.6.E974

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  24 in total

Review 1.  Adverse effects of creatine supplementation: fact or fiction?

Authors:  J R Poortmans; M Francaux
Journal:  Sports Med       Date:  2000-09       Impact factor: 11.136

Review 2.  New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle.

Authors:  Francis B Stephens; Dumitru Constantin-Teodosiu; Paul L Greenhaff
Journal:  J Physiol       Date:  2007-03-01       Impact factor: 5.182

Review 3.  Creatine and its potential therapeutic value for targeting cellular energy impairment in neurodegenerative diseases.

Authors:  Peter J Adhihetty; M Flint Beal
Journal:  Neuromolecular Med       Date:  2008-11-13       Impact factor: 3.843

4.  Effects of creatine supplementation on cognitive function of healthy individuals: A systematic review of randomized controlled trials.

Authors:  Konstantinos I Avgerinos; Nikolaos Spyrou; Konstantinos I Bougioukas; Dimitrios Kapogiannis
Journal:  Exp Gerontol       Date:  2018-04-25       Impact factor: 4.032

5.  Effects of long-term creatine feeding and running on isometric functional measures and myosin heavy chain content of rat skeletal muscles.

Authors:  Maria Gallo; Tessa Gordon; Daniel Syrotuik; Yang Shu; Neil Tyreman; Ian MacLean; Zoltan Kenwell; Charles T Putman
Journal:  Pflugers Arch       Date:  2006-05-11       Impact factor: 3.657

Review 6.  Creatine and the creatine transporter: a review.

Authors:  R J Snow; R M Murphy
Journal:  Mol Cell Biochem       Date:  2001-08       Impact factor: 3.396

Review 7.  X-linked creatine transporter deficiency: clinical aspects and pathophysiology.

Authors:  Jiddeke M van de Kamp; Grazia M Mancini; Gajja S Salomons
Journal:  J Inherit Metab Dis       Date:  2014-05-01       Impact factor: 4.982

Review 8.  Creatine supplementation in health and disease: what is the evidence for long-term efficacy?

Authors:  Wim Derave; Bert O Eijnde; Peter Hespel
Journal:  Mol Cell Biochem       Date:  2003-02       Impact factor: 3.396

9.  Fenugreek increases insulin-stimulated creatine content in L6C11 muscle myotubes.

Authors:  Kristyen A Tomcik; William J Smiles; Donny M Camera; Helmut M Hügel; John A Hawley; Rani Watts
Journal:  Eur J Nutr       Date:  2016-01-05       Impact factor: 5.614

10.  Creatine supplementation increases glucose oxidation and AMPK phosphorylation and reduces lactate production in L6 rat skeletal muscle cells.

Authors:  Rolando B Ceddia; Gary Sweeney
Journal:  J Physiol       Date:  2004-01-14       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.